Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies

Authors:

Abstract
This article reports the design, synthesis, and evaluation of a novel class of molecules of intermediate size (approximately 7000 Da), which possess both the targeting and effector functions of antibodies. These compounds—called synthetic antibody mimics targeting prostate cancer (SyAM-Ps)—bind simultaneously to prostate-specific membrane antigen and Fc gamma receptor I, thus eliciting highly selective cancer cell phagocytosis. SyAMs have the potential to combine the advantages of both small-molecule and biologic therapies, and may address many drawbacks associated with available treatments for cancer and other diseases.
Funding Information
  • Bristol-Myers Squibb (OCR4997.11)
  • National Institute of General Medical Sciences (GM100283-01)

This publication has 76 references indexed in Scilit: